ArticleClinical case reports2026
Case Report: Extrusion of a Sacral Nerve Implant Due to Engaging in Heavy Labor.
Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sacral neuromodulation (SNM) is an effective treatment option for patients with an overactive bladder, non-obstructive retention, and fecal incontinence. Although the risk of device extrusion is relatively low, if it occurs, it can lead to severe complications and undermine clinical outcomes. Here, we report on a patient who experienced two episodes of device extrusion related to engaging in heavy labor. During treatments, we reimplanted the device successfully and highlight the importance of anti-infective therapy. Specifically, salvage management included urgent debridement with high-volume irrigation using 2 L of antibiotic solution, relocation of SNM device to a deeper subcutaneous plane (approximately 2 cm), and postoperative antibiotic therapy for 7 days. At the 7-month follow-up, the patient showed no evidence of recurrence. We then reviewed 9 cases related to the migration and extrusion of SNM implants, summarizing the clinical characteristics, possible triggers, and optimal treatment for clinicians when encountering similar situations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.